{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:49:28Z","timestamp":1790660968063,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine & Growth Factor Reviews"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.cytogfr.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T12:37:07Z","timestamp":1552912627000},"page":"28-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Insulin-like growth factor binding proteins and angiogenesis: from cancer to cardiovascular disease"],"prefix":"10.1016","volume":"46","author":[{"given":"Thomas","family":"Slater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie J","family":"Haywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harneet","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B","family":"Wheatcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2019.03.005_bib0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0010","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd1226","article-title":"Therapeutic angiogenesis in cardiovascular disease","volume":"2","author":"Simons","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/bdrc.21010","article-title":"Pattern formation during vasculogenesis","volume":"96","author":"Czirok","year":"2012","journal-title":"Birth Defects Res C Embryo Today"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1054\/bjoc.1999.0931","article-title":"Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models","volume":"82","author":"Lee","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","article-title":"Basic and therapeutic aspects of angiogenesis","volume":"146","author":"Potente","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0035","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0040","series-title":"Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy","first-page":"67","article-title":"The Angiogenic Switch in Tumorigenesis","author":"Wicki","year":"2008"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0045","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cvr\/28.8.1176","article-title":"Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis","volume":"28","author":"Banai","year":"1994","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0050","doi-asserted-by":"crossref","first-page":"e5208","DOI":"10.1136\/bmj.e5208","article-title":"Diagnosis and management of peripheral arterial disease","volume":"345","author":"Peach","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.med.58.061705.145635","article-title":"Targeting VEGF-A to treat cancer and age-related macular degeneration","volume":"58","author":"Ferrara","year":"2007","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1749-8090-2-49","article-title":"Therapeutic angiogenesis in cardiovascular disease","volume":"2","author":"Al Sabti","year":"2007","journal-title":"J Cardiothorac Surg"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0065","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0003-4975(00)02018-X","article-title":"Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia","volume":"70","author":"Sato","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.97.7.645","article-title":"Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease","volume":"97","author":"Schumacher","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0075","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nm1095-1085","article-title":"Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis","volume":"1","author":"Pearlman","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0080","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1253\/jcj.65.845","article-title":"Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results","volume":"65","author":"Hamano","year":"2001","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","article-title":"Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial","volume":"360","author":"Tateishi-Yuyama","year":"2002","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0090","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.CIR.0000061911.47710.8A","article-title":"The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis","volume":"107","author":"Henry","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0095","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/CIRCRESAHA.116.309045","article-title":"Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies","volume":"120","author":"Rigato","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0100","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1161\/01.CIR.94.12.3281","article-title":"Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion","volume":"94","author":"Tsurumi","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0105","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/01.CIR.97.12.1114","article-title":"Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia","volume":"97","author":"Baumgartner","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0110","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/S0002-8703(99)70333-9","article-title":"Gene therapy for myocardial angiogenesis","volume":"138","author":"Losordo","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0115","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/gt.2012.17","article-title":"VEGF gene therapy: Therapeutic angiogenesis in the clinic and beyond","volume":"19","author":"Giacca","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0120","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(11)60394-2","article-title":"Effect of fibroblast growth factor NV1FGF on amputation and death: A randomised placebo-controlled trial of gene therapy in critical limb ischaemia","volume":"377","author":"Belch","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0125","first-page":"1","article-title":"The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes","author":"Haywood","year":"2018","journal-title":"Mol Metab"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1517\/14728222.2014.858698","article-title":"Insulin growth factor binding proteins as therapeutic targets in type 2 diabetes","volume":"18","author":"Hjortebjerg","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0135","article-title":"Endothelial cells and the IGF system","volume":"54","author":"Bach","year":"2015","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10456-018-9597-6","article-title":"Direct repression of IGF2 is implicated in the anti-angiogenic function of microRNA-210 in human retinal endothelial cells","volume":"21","author":"Yang","year":"2018","journal-title":"Angiogenesis"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"Duan C. IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.ATV.0000105902.89459.09","article-title":"Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels","volume":"24","author":"Delafontaine","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0155","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","article-title":"Role of the insulin-like growth factor family in cancer development and progression","volume":"92","author":"Yu","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tem.2009.01.002","article-title":"IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis","volume":"20","author":"Wheatcroft","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0165","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.112.268110","article-title":"RTEF-1 attenuates blood glucose levels by regulating insulin-like growth factor binding protein-1 in the endothelium","volume":"111","author":"Messmer-Blust","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2337\/db16-0997","article-title":"Insulin-Like Growth Factor Binding Protein 1 Could Improve Glucose Regulation and Insulin Sensitivity Through Its RGD Domain","volume":"66","author":"Haywood","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0175","first-page":"2497","article-title":"Insulin-Like Growth Factor Binding Protein 1 Stimulates Cell Migration and Binds to the alpha5beta1 Integrin by Means of its Arg-Gly-Asp Sequence","volume":"8","author":"Jones","year":"1993","journal-title":"EMBO J"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0180","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd2359","article-title":"Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer","volume":"6","author":"Clemmons","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0185","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2337\/diabetes.52.8.2075","article-title":"Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1","volume":"52","author":"Wheatcroft","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0190","first-page":"5645","article-title":"Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma","volume":"7","author":"Dai","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0195","doi-asserted-by":"crossref","first-page":"23401","DOI":"10.1074\/jbc.M115.664037","article-title":"Glioblastoma-derived macrophage colony-stimulating factor (MCSF) induces microglial release of insulin-like growth factor-binding protein 1 (IGFBP1) to promote angiogenesis","volume":"290","author":"Nijaguna","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095180","article-title":"Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi\/NF-kB-dependent angiogenic factor expression","volume":"9","author":"Chuang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0205","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2337\/db11-0963","article-title":"Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis","volume":"61","author":"Rajwani","year":"2012","journal-title":"Diabetes"},{"issue":"Suppl","key":"10.1016\/j.cytogfr.2019.03.005_bib0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1567-5688(03)00034-5","article-title":"NO and angiogenesis","volume":"4","author":"Cooke","year":"2003","journal-title":"Atheroscler"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR Pathway in Angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0220","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cardiores.2004.07.012","article-title":"Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice","volume":"64","author":"Peng","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0225","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1167\/iovs.10-5888","article-title":"Inhibition of angiogenesis by HC\u00b7HA, a complex of hyaluronan and the heavy chain of inter-\u03b1-Inhibitor, purified from human amniotic membrane","volume":"52","author":"Shay","year":"2011","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0230","first-page":"761","article-title":"The insulin-like growth factor-binding protein (IGFBP) superfamily","volume":"20","author":"Hwa","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0235","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1210\/en.2005-0467","article-title":"Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion","volume":"146","author":"Russo","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0240","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1507\/endocrj.EJ12-0080","article-title":"Influence of catch-up growth on IGFBP-2 levels and association between IGFBP-2 and cardiovascular risk factors in Korean children born SGA","volume":"59","author":"Ko","year":"2012","journal-title":"Endocr J"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2337\/db06-0436","article-title":"IGF-binding protein-2 protects against the development of obesity and insulin resistance","volume":"56","author":"Wheatcroft","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0250","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/me.2004-0392","article-title":"Targeted knockdown of insulin-like growth factor binding protein-2 disrupts cardiovascular development in zebrafish embryos","volume":"19","author":"Wood","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0255","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2202-14-158","article-title":"Spatial distribution of insulin-like growth factor binding protein-2 following hypoxic-ischemic injury","volume":"14","author":"Fletcher","year":"2013","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0260","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/en.2011-1121","article-title":"IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells","volume":"152","author":"Azar","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0265","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/onc.2012.630","article-title":"IGFBP-2 nuclear translocation is mediated by a functional NLS sequence and is essential for its pro-tumorigenic actions in cancer cells","volume":"33","author":"Azar","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0270","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1073\/pnas.1120375109","article-title":"Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF- B network","volume":"109","author":"Holmes","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0275","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/0008-5472.CAN-12-1681","article-title":"MDA-9\/syntenin and IGFBP-2 promote angiogenesis in human melanoma","volume":"73","author":"Das","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0280","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nature06487","article-title":"Endogenous human microRNAs that suppress breast cancer metastasis","volume":"451","author":"Tavazoie","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0285","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nature10661","article-title":"A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells","volume":"481","author":"Png","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0290","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1128\/MCB.01011-12","article-title":"Insulin-Like Growth Factor (IGF) Binding Protein 2 Functions Coordinately with Receptor Protein Tyrosine Phosphatase and the IGF-I Receptor To Regulate IGF-I-Stimulated Signaling","volume":"32","author":"Shen","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0295","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.4161\/cbt.5.10.3455","article-title":"Insulin-Like Growth Factor Factor Binding Protein-2 is a Novel Mediator of p53 Inhibition of Insulin-Like Growth Factor Signaling","volume":"5","author":"Grimberg","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0300","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1538-7836.2007.02431.x","article-title":"Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms","volume":"5","author":"Granata","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0305","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1167\/iovs.03-0565","article-title":"IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407","volume":"45","author":"Slomiany","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0310","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.0702031104","article-title":"IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth","volume":"104","author":"Lofqvist","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0315","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.0702072104","article-title":"IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development","volume":"104","author":"Chang","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0320","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.yjmcc.2016.06.005","article-title":"Cardiac atrial appendage stem cells promote angiogenesis in vitro and in vivo","volume":"97","author":"Fanton","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0325","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2010-08-299784","article-title":"Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1\/2 activation and Egr-1-mediated transcriptional events","volume":"118","author":"Kim","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0330","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.18632\/oncotarget.3825","article-title":"Insulin-like growth factor binding protein-3 inhibits cell adhesion via suppression of integrin \u03b24 expression","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0335","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/eurheartj\/ehr365","article-title":"Peroxisome proliferator-activated receptor-\u03b4 activates endothelial progenitor cells to induce angio-myogenesis through matrix metallo-proteinase-9-mediated insulin-like growth factor-1 paracrine networks","volume":"34","author":"Han","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0340","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1349-7006.2012.02301.x","article-title":"Insulin-like growth factor binding protein-3 suppresses vascular endothelial growth factor expression and tumor angiogenesis in head and neck squamous cell carcinoma","volume":"103","author":"Oh","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0345","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.onc.1208287","article-title":"Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3","volume":"24","author":"Iwatsuki","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0350","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1158\/1078-0432.CCR-05-1725","article-title":"Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma","volume":"12","author":"Oh","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0355","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/mgme.1999.2920","article-title":"Novel aspects of the insulin-like growth factor binding proteins","volume":"68","author":"Wetterau","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0360","first-page":"883","article-title":"Insulin-like growth factor binding protein-4 gene therapy increases apoptosis by altering Bcl-2 and Bax proteins and decreases angiogenesis in colorectal cancer","volume":"30","author":"Durai","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0365","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1074\/jbc.M111.267732","article-title":"Insulin-like Growth Factor Binding Protein-4 Differentially Inhibits Growth Factor-induced Angiogenesis","volume":"287","author":"Contois","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0370","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.bjc.6605141","article-title":"Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer","volume":"101","author":"Ryan","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0375","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1186\/s12885-018-4950-0","article-title":"Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer","volume":"18","author":"Smith","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0380","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/glia.20345","article-title":"Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells","volume":"53","author":"Moreno","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0385","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1593\/neo.13212","article-title":"IGFBP-4 Anti-Angiogenic and Anti-Tumorigenic Effects Are Associated with Anti-Cathepsin B Activity","volume":"15","author":"Moreno","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0390","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1074\/jbc.273.11.6074","article-title":"Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit","volume":"273","author":"Twigg","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0395","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/carcin\/bgn206","article-title":"Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis","volume":"29","author":"Rho","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep39334","article-title":"The C-terminus of IGFBP-5 suppresses tumor growth by inhibiting angiogenesis","volume":"6","author":"Hwang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0405","doi-asserted-by":"crossref","first-page":"20563","DOI":"10.1074\/jbc.M200885200","article-title":"Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1\/2 pathways","volume":"277","author":"Kuemmerle","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0410","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1210\/endo.141.6.7520","article-title":"Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3\u2032-kinase pathway","volume":"141","author":"Miyake","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0415","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3892\/mmr.2013.1794","article-title":"Expression of IGFBP-6 in proliferative vitreoretinopathy rat models and its effects on retinal pigment epithelial-J cells","volume":"9","author":"Zhu","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0420","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12079-015-0288-4","article-title":"Recent insights into the actions of IGFBP-6","volume":"9","author":"Bach","year":"2015","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0425","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/ijc.26201","article-title":"IGF binding protein-6 expression in vascular endothelial cells is induced by hypoxia and plays a negative role in tumor angiogenesis","volume":"130","author":"Zhang","year":"2012","journal-title":"Int J cancer"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0430","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3233\/CBM-170947","article-title":"Correlation of IGFBP-6 expression with apoptosis and migration of colorectal carcinoma cells","volume":"21","author":"Qiu","year":"2018","journal-title":"Cancer Biomark"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0435","doi-asserted-by":"crossref","first-page":"22298","DOI":"10.1074\/jbc.M703066200","article-title":"Promotion of cancer cell migration: An insulin-like growth factor (IGF)-independent action of IGF-binding protein-6","volume":"282","author":"Fu","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0440","first-page":"231","article-title":"Differential Effects of Insulin-Like Growth Factor Binding Protein-6 (IGFBP-6) on Migration of Two Ovarian Cancer Cell Lines","volume":"5","author":"Yang","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0445","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.bbrc.2003.09.058","article-title":"Proteolytic processing of IGFBP-related protein-1 (TAF\/angiomodulin\/mac25) modulates its biological activity","volume":"310","author":"Ahmed","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0450","doi-asserted-by":"crossref","first-page":"30322","DOI":"10.1074\/jbc.271.48.30322","article-title":"Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II","volume":"271","author":"Oh","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0455","first-page":"1","article-title":"IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by Insulin-Like Growth Factors","volume":"5","author":"Evdokimova","year":"2012","journal-title":"Sciecne Signal"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0460","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1021\/pr300010r","article-title":"Proteomic screen identifies IGFBP7 as a novel component of endothelial cell-specific Weibel-Palade bodies","volume":"11","author":"van Breevoort","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0465","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.1038\/onc.2008.287","article-title":"Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling","volume":"27","author":"Pen","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0470","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/mt.2012.282","article-title":"Insulin-like Growth Factor-binding Protein-7 (IGFBP7): A Promising Gene Therapeutic for Hepatocellular Carcinoma (HCC)","volume":"21","author":"Chen","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0475","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1158\/1078-0432.CCR-10-2774","article-title":"Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma","volume":"17","author":"Chen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0480","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2009.01.045","article-title":"Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells","volume":"610","author":"Tamura","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0485","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1262\/jrd.2014-069","article-title":"Inhibitory effect of insulin-like growth factor-binding protein-7 (IGFBP7) on in vitro angiogenesis of vascular endothelial cells in the rat corpus luteum","volume":"60","author":"Tamura","year":"2014","journal-title":"J Reprod Dev"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0490","first-page":"981","article-title":"Intratumoral injection of pEGFC1-IGFBP7 inhibits malignant melanoma growth in C57BL \/ 6J mice by inducing apoptosis and down-regulating VEGF expression","volume":"23","author":"Chen","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0495","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/02713683.2010.545498","article-title":"Insulin-like growth factor binding protein-related protein 1 mediates VEGF-induced proliferation, migration and tube formation of retinal endothelial cells","volume":"36","author":"Sun","year":"2011","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.cytogfr.2019.03.005_bib0500","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/mrd.21143","article-title":"Knockdown of IGF-Binding Protein 7 Inhibits Transformation of the Endometrial Gland in an In Vitro Model","volume":"272","author":"Kutsukake","year":"2010","journal-title":"Mol Reprod Dev"}],"container-title":["Cytokine & Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610119300103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610119300103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:54:38Z","timestamp":1761216878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610119300103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":100,"alternative-id":["S1359610119300103"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2019.03.005","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin-like growth factor binding proteins and angiogenesis: from cancer to cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}